BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 2284800)

  • 1. [The late results of treating membranous glomerulonephritis].
    Belovezhdov N; Robeva R; Dimitrova V
    Vutr Boles; 1990; 29(3):53-60. PubMed ID: 2284800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
    Dumoulin A; Hill GS; Montseny JJ; Meyrier A
    Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.
    du Buf-Vereijken PW; Branten AJ; Wetzels JF;
    Nephrol Dial Transplant; 2004 May; 19(5):1142-8. PubMed ID: 14993502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
    Goumenos DS; Katopodis KP; Passadakis P; Vardaki E; Liakopoulos V; Dafnis E; Stefanidis I; Vargemezis V; Vlachojannis JG; Siamopoulos KC
    Am J Nephrol; 2007; 27(3):226-31. PubMed ID: 17389782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
    Goumenos DS; Ahuja M; Davlouros P; El Nahas AM; Brown CB
    Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous remission of nephrotic syndrome in membranous nephropathy with chronic renal impairment.
    Polanco N; Gutiérrez E; Rivera F; Castellanos I; Baltar J; Lorenzo D; Praga M;
    Nephrol Dial Transplant; 2012 Jan; 27(1):231-4. PubMed ID: 21624942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of membranous lupus nephritis.
    Moroni G; Maccario M; Banfi G; Quaglini S; Ponticelli C
    Am J Kidney Dis; 1998 Apr; 31(4):681-6. PubMed ID: 9531186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiopathic membranous glomerulonephritis: long-term follow-up in 139 cases.
    Murphy BF; Fairley KF; Kincaid-Smith PS
    Clin Nephrol; 1988 Oct; 30(4):175-81. PubMed ID: 3214963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
    Branten AJ; Wetzels JF
    Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive treatment of the glomerulonephritis of systemic lupus.
    Faedda R; Palomba D; Satta A; Pirisi M; Tanda F; Bartoli E
    Clin Nephrol; 1995 Dec; 44(6):367-75. PubMed ID: 8719548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy.
    Hofstra JM; Deegens JK; Willems HL; Wetzels JF
    Nephrol Dial Transplant; 2008 Aug; 23(8):2546-51. PubMed ID: 18308774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of cyclophosphamide on the length of remission in patients suffering from glomerulonephritis with nephrotic syndrome].
    Duman VL; Shkerina LI; Shilov EM
    Klin Med (Mosk); 2005; 83(10):48-50. PubMed ID: 16320847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term prognosis of chronic idiopathic membranous glomerulonephritis. An analysis of 334 cases with particular regard to tubulo-interstitial changes.
    Wehrmann M; Bohle A; Bogenschütz O; Eissele R; Freislederer A; Ohlschlegel C; Schumm G; Batz C; Gärtner HV
    Clin Nephrol; 1989 Feb; 31(2):67-76. PubMed ID: 2920470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic membranous nephropathy: outline and rationale of a treatment strategy.
    du Buf-Vereijken PW; Branten AJ; Wetzels JF
    Am J Kidney Dis; 2005 Dec; 46(6):1012-29. PubMed ID: 16310567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of immunosuppressive therapy in idiopathic membranous nephropathy.
    Maas R; Hofstra JM; Wetzels JF
    Minerva Med; 2012 Aug; 103(4):253-66. PubMed ID: 22805618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions.
    Faedda R; Pirisi M; Satta A; Tanda F; Bartoli E
    Clin Nephrol; 1996 Oct; 46(4):237-44. PubMed ID: 8905208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis of untreated patients with idiopathic membranous nephropathy.
    Schieppati A; Mosconi L; Perna A; Mecca G; Bertani T; Garattini S; Remuzzi G
    N Engl J Med; 1993 Jul; 329(2):85-9. PubMed ID: 8510707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome.
    Alexopoulos E; Papagianni A; Tsamelashvili M; Leontsini M; Memmos D
    Nephrol Dial Transplant; 2006 Nov; 21(11):3127-32. PubMed ID: 16968719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiopathic membranous nephropathy: diagnosis and treatment.
    Fervenza FC; Sethi S; Specks U
    Clin J Am Soc Nephrol; 2008 May; 3(3):905-19. PubMed ID: 18235148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunosuppressive therapy in IgA glomerulonephritis with chronic renal failure: case study presentation and literature review].
    Pozzi C; Del Vecchio L; Locatelli F
    G Ital Nefrol; 2002; 19(5):523-8. PubMed ID: 12439840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.